Top News
Latest News
PARTNERSHIPS
8 Dec 2025
Can BioNTech’s CureVac Deal Spark a Biotech Revival?PARTNERSHIPS
3 Dec 2025
A Power Partnership Pushes Europe’s mRNA AmbitionsMARKET TRENDS
24 Oct 2025
From Covid to Cancer, Europe’s mRNA Strategy Takes ShapeINSIGHTS
25 Sep 2025
UK mRNA Hub Signals a New Chapter for Biotech Growth
A Faster Future for mRNA, Powered by AI
INNOVATION
31 Aug 2025
GEMORNA advances mRNA design with AI and shows strong gains in early research
PARTNERSHIPS
8 Dec 2025
Can BioNTech’s CureVac Deal Spark a Biotech Revival?
BioNTech’s $1.25bn acquisition of CureVac brings two early mRNA pioneers together as Europe seeks scale in a competitive global market
PARTNERSHIPS
3 Dec 2025
A Power Partnership Pushes Europe’s mRNA Ambitions
Ethris and Thermo Fisher team up to scale stable mRNA innovations and advance the SNIM RNA platform
MARKET TRENDS
24 Oct 2025
From Covid to Cancer, Europe’s mRNA Strategy Takes Shape
Targeted funding and new facilities show a steady push to extend mRNA science beyond Covid-era vaccines
INSIGHTS
25 Sep 2025
UK mRNA Hub Signals a New Chapter for Biotech Growth
New Oxfordshire facility strengthens vaccine production and positions UK as key player in mRNA therapeutics
INNOVATION
31 Aug 2025
A Faster Future for mRNA, Powered by AI
GEMORNA advances mRNA design with AI and shows strong gains in early research
INNOVATION
9 Aug 2025
How Smarter Delivery Could Redefine mRNA Therapies
Preclinical antibody-guided delivery suggests mRNA could move beyond vaccines toward more precise cancer and immune therapies
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.